Development of Doxazosin mesylate liquisolid system for improved manufacturing processability and bioavailability: in vitro and in vivo evaluation for tailored hypertension treatment approach with modified dissolution rates

References

• Savjani, K. T.; Gajjar, A. K.; Savjani, J. K. Drug Solubility: Importance and Enhancement Techniques. Inter. Sch. Re. Not. 2012, 2012, 1–10. DOI: 10.5402/2012/195727.
   Google Scholar
• Kumar, A.; Sahoo, S. K.; Padhee, K.; Kochar, P. S.; Sathapathy, A.; Pathak, N. Review on Solubility Enhancement Techniques for Hydrophobic Drugs. Pharm. Glob. (IJCP) 2011, 3, 001–007.
   Google Scholar
• Kalepu, S.; Nekkanti, V. Insoluble Drug Delivery Strategies: Review of Recent Advances and Business Prospects. Acta Pharm. Sin. B 2015, 5, 442–453. DOI: 10.1016/j.apsb.2015.07.003.
   PubMed Web of Science ®Google Scholar
• Bhakay, A.; Rahman, M.; Dave, R. N.; Bilgili, E. Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation-Processing Aspects and Challenges. Pharmaceutics 2018, 10, 86. DOI: 10.3390/pharmaceutics10030086.
   PubMed Web of Science ®Google Scholar
• Khadka, P.; Ro, J.; Kim, H.; Kim, I.; Kim, J. T.; Kim, H.; Cho, J. M.; Yun, G.; Lee, J. Pharmaceutical Particle Technologies: An Approach to Improve Drug Solubility, Dissolution and Bioavailability. Asian J. Pharm. Sci. 2014, 9, 304–316. DOI: 10.1016/j.ajps.2014.05.005.
   Google Scholar
• Cerpnjak, K.; Zvonar, A.; Gasperlin, M.; Vrecer, F. Lipid-Based Systems as Promising Approach for Enhancing the Bioavailability of Poorly Water-Soluble Drugs. Acta Pharm. 2013, 63, 427–445. DOI: 10.2478/acph-2013-0040.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Aller, M.; Guillarme, D.; Veuthey, J. L.; Gurny, R. Strategies for Formulating and Delivering Poorly Water-Soluble Drugs. J. Drug Deliv. Sci. Technol. 2015, 30, 324–351. DOI: 10.1016/j.jddst.2015.05.009.
   Web of Science ®Google Scholar
• Stegemann, S.; Leveiller, F.; Franchi, D.; De Jong, H.; Linden, H. When Poor Solubility Becomes an Issue: From Early Stage to Proof of Concept. Eur. J. Pharm. Sci. 2007, 31, 249–261. DOI: 10.1016/j.ejps.2007.05.110.
   PubMed Web of Science ®Google Scholar
• Sikarra, D.; Shukla, V.; Kharia, A. A.; Chatterjee, D. P. Techniques for Solubility Enhancement of Poorly Soluble Drugs: An Overview. J. Med. Pharm. Allied Sci. 2012, 1, 1–22.
   Google Scholar
• Patel, S.; Patel, D.; Patel, C.; Patel, T.; Prajapati, P.; Parikh, B. Self Emulsifying Drug Delivery System. J. Glob. Pharma. Technol. 2010, 2, 29–37.
   Google Scholar
• Singh, M. C.; Sayyad, A. B.; Sawant, S. D. Review on Various Techniques of Solubility Enhancement of Poorly Soluble Drugs with Special Emphasis on Solid Dispersion. J. Pharm. Res 2010, 3, 2494–2501.
   Google Scholar
• Jagtap, S.; Magdum, C.; Jadge, D.; Jagtap, R. Solubility Enhancement Technique: A Review. J. Pharm. Sci. Res. 2018, 10, 2205–2211.
   Google Scholar
• Loh, Z. H.; Samanta, A. K.; Heng, P. W. Overview of Milling Techniques for Improving the Solubility of Poorly Water-Soluble Drugs. Asian J. Pharm. Sci. 2015, 10, 255–274. DOI: 10.1016/j.ajps.2014.12.006.
   Web of Science ®Google Scholar
• Hajare, A. A.; More, H. N. Design of the Lyophilization Process of a Doxorubicin Formulation Based on Thermal Properties. Pharmaceut. Sci. 2017, 79, 907–913. DOI: 10.4172/pharmaceutical-sciences.1000307.
   Web of Science ®Google Scholar
• Challa, R.; Ahuja, A.; Ali, J.; Khar, R. K. Cyclodextrins in Drug Delivery: An Updated Review. AAPS PharmSciTech 2005, 6, E329–57. DOI: 10.1208/pt060243.
   PubMed Web of Science ®Google Scholar
• Nayak, A. K.; Panigrahi, P. P. Solubility Enhancement of Etoricoxib by Cosolvency Approach. ISRN Phy. Chem. 2012, 2012, 1–5. DOI: 10.5402/2012/820653.
   Google Scholar
• Tiong, N.; Elkordy, A. A. Effects of Liquisolid Formulations on Dissolution of Naproxen. Eur. J. Pharm. Biopharm. 2009, 73, 373–384. DOI: 10.1016/j.ejpb.2009.08.002.
   PubMed Web of Science ®Google Scholar
• Javadzadeh, Y.; Siahi-Shadbad, M.; Barzegar-Jalali, M.; Nokhodchi, A. Enhancement of Dissolution Rate of Piroxicam Using Liquisolid Compacts. Farmaco 2005, 60, 361–365. DOI: 10.1016/j.farmac.2004.09.005.
   PubMedGoogle Scholar
• Javadzadeh, Y.; Jafari-Navimipour, B.; Nokhodchi, A. Liquisolid Technique for Dissolution Rate Enhancement of a High Dose Water-Insoluble Drug (Carbamazepine). Int. J. Pharm. 2007, 341, 26–34. DOI: 10.1016/j.ijpharm.2007.03.034.
   PubMed Web of Science ®Google Scholar
• El-Houssieny, B. M.; Wahman, L.; Arafa, N. Bioavailability and Biological Activity of Liquisolid Compact Formula of Repaglinide and Its Effect on Glucose Tolerance in Rabbits. Biosci. Trends. 2010, 4, 17–24.
   PubMed Web of Science ®Google Scholar
• Fahmy, R. H.; Kassem, M. A. Enhancement of Famotidine Dissolution Rate through Liquisolid Tablets Formulation: In Vitro and in Vivo Evaluation. Eur. J. Pharm. Biopharm. 2008, 69, 993–1003. DOI: 10.1016/j.ejpb.2008.02.017.
   PubMed Web of Science ®Google Scholar
• Emeje, M.; John-Africa, L.; Isimi, Y.; Kunle, O.; Ofoefule, S. Eudraginated Polymer Blends: A Potential Oral Controlled Drug Delivery System for Theophylline. Acta Pharm. 2012, 62, 71–82. DOI: 10.2478/v10007-012-0001-6.
   PubMed Web of Science ®Google Scholar
• Khaled, K. A.; Asiri, Y. A.; El-Sayed, Y. M. In Vivo Evaluation of Hydrochlorothiazide Liquisolid Tablets in Beagle Dogs. Int. J. Pharm. 2001, 222, 1–6. DOI: 10.1016/s0378-5173(01)00633-0.
   PubMed Web of Science ®Google Scholar
• Gubbi, S.; Jarag, R. Formulation and Characterization of Atorvastatin Calcium Liquisolid Compacts. Asian J. Pharm. Sci. 2010, 5, 50–60.
   Google Scholar
• Jadhav, N. R.; Irny, P. V.; Patil, U. S. Solid State Behavior of Progesterone and Its Release from Neusilin US2 Based Liquisolid Compacts. J. Drug Deliv. Sci. Technol. 2017, 38, 97–106. DOI: 10.1016/j.jddst.2017.01.009.
   Web of Science ®Google Scholar
• Dias, R. J.; Mali, K. K.; Ghorpade, V. S.; Havaldar, V. D.; Mohite, V. R. Formulation and Evaluation of Carbamazepine Liquisolid Compacts Using Novel Carriers. IJPER. 2017, 51, S69–s78. DOI: 10.5530/ijper.51.2s.52.
   Web of Science ®Google Scholar
• Shete, A.; Salunkhe, A.; Yadav, A.; Sakhare, S.; Doijad, R. Neusilin Based Liquisolid Compacts of Albendazole: Design, Development, Characterization and in Vitro Anthelmintic Activity. JRP. 2019, 23, 441–456. DOI: 10.12991/jrp.2019.151.
   Web of Science ®Google Scholar
• Yadav, A. V.; Shete, A. S.; Dabke, A. P. Formulation and Evaluation of Orodispersible Liquisolid Compacts of Aceclofenac. Indian J. Pharm. Educ. Res. 2010, 44, 227–235.
   Web of Science ®Google Scholar
• Sanket, J.; Sujit, P.; Rampal, S. M.; Nikhlesh, B. Formulation and Evaluation of Fast Dissolving Tablet of Ondansetron by Utilizing Liquisolid Compact Technique. Res. J. Pharmacogn. Phytochem. 2021, 13, 163–168. DOI: 10.52711/0975-4385.2021.00027.
   Google Scholar
• Jaydip, B.; Dhaval, M.; Soniwala, M. M.; Chavda, J. Formulation and Optimization of Liquisolid Compact for Improving the Dissolution Profile of Efavirenz by Using DoE Approach. Saudi Pharm. J. 2020, 28, 737–745. DOI: 10.1016/j.jsps.2020.04.016.
   PubMed Web of Science ®Google Scholar
• Sulaiman, H. T.; Jaber, S. H. Effect of Formulation Parameter on Dissolution Rate of Flurbiprofen Using Liquisolid Compact. JPRI. 2021, 42A, 289–306. DOI: 10.9734/jpri/2021/v33i42A32408.
   Web of Science ®Google Scholar
• Barbora, V.; Jan, G. Evaluation of Sorptive Properties of Various Carriers and Coating Materials for Liquisolid Systems. Acta Pol. Pharm. 2015, 3, 539–549.
   Google Scholar
• Ali, B.; Khan, A.; Alyami, H. S.; Ullah, M.; Wahab, A.; Badshah, M.; Naz, A. Evaluation of the Effect of Carrier Material on Modification of Release Characteristics of Poor Water Soluble Drug from Liquisolid Compacts. PLoS One. 2021, 16, e0249075. DOI: 10.1371/journal.pone.0249075.
   PubMed Web of Science ®Google Scholar
• Yadav, P. S.; Kondawar, M. S.; Varne, B. S. Enhancement of Dissolution Properties of Candesartan Using Liquisolid Technique. Int. J. Adv. Pharm. Res. 2013, 4, 2503–2513.
   Google Scholar
• Elkordy, A. A.; Tan, X. N.; Essa, E. A. Spironolactone Release from Liquisolid Formulations Prepared with Capryol™ 90, Solutol® HS-15 and Kollicoat® SR 30 D as Non-Volatile Liquid Vehicles. Eur. J. Pharm. Biopharm. 2013, 83, 203–223. DOI: 10.1016/j.ejpb.2012.08.004.
   PubMed Web of Science ®Google Scholar
• Spireas, S.; Bolton, S. Liquisolid Systems and Methods of Preparing Same. US5800834A, 1998. http://www.google.com/patents/US5800834.
   Google Scholar
• Karmarkar, A. B. Effect of Ceolus KG-802 on the Dissolution Rate of Fenofibrate Liquisolid Tablets: Preformulation and Formulation Development Studies. Drug Discov. Ther. 2010, 30, 40.
   Google Scholar
• Yadav, P. S.; Hajare, A. A.; Patil, K. S. Development and Validation of UV Spectrophotometric Method for Doxazosin Mesylate in Bulk and Tablets. Res. J. Pharm. Technol. 2022, 15, 2675–2680. DOI: 10.52711/0974-360X.2022.00447.
   Google Scholar
• Naidu, N. V.; Reddy, M. R.; Suguna, P. Development and Validation of the HPLC Method for the Analysis of Doxazosin in Bulk Drug and Pharmaceutical Dosage Forms. Int. J. Pharm. Sci. 2012, 3, 2705–2711. DOI: 10.13040/IJPSR.0975-8232.3(8).2705-11.
   Google Scholar
• Pathak, B. K.; Raghav, M.; Thakkar, A. R.; Vyas, B. A.; Shah, P. J. Enhanced Oral Bioavailability of Etodolac by the Liquisolid Compact Technique: Optimization, in-Vitro and in-Vivo Evaluation. Curr. Drug Deliv. 2021, 18, 471–486. DOI: 10.2174/1567201817666201026111559.
   PubMed Web of Science ®Google Scholar
• Jaipakdee, N.; Limpongsa, E.; Sripanidkulchai, B. O.; Piyachaturawat, P. Preparation of Curcuma Comosa Tablets Using Liquisolid Techniques: In Vitro and in Vivo Evaluation. Int. J. Pharm. 2018, 553, 157–168. DOI: 10.1016/j.ijpharm.2018.10.031.
   PubMed Web of Science ®Google Scholar
• Zhang, Y.; Huo, M.; Zhou, J.; Xie, S. PKSolver: An Add-in Program for Pharmacokinetic and Pharmacodynamic Data Analysis in Microsoft Excel. Comput. Methods Programs Biomed. 2010, 99, 306–314. DOI: 10.1016/j.cmpb.2010.01.007.
   PubMed Web of Science ®Google Scholar
• Venkatesh, D. N.; Meyyanathan, S. N.; Shanmugam, R.; Zielinska, A.; Campos, J. R.; Ferreira, J. D.; Souto, E. B. Development, in Vitro Release and in Vivo Bioavailability of Sustained Release Nateglinide Tablets. J. Drug Deliv. Sci. Techno.l 2020, 55, 101355. DOI: 10.1016/j.jddst.2019.101355.
   Web of Science ®Google Scholar
• Product information brochure: Fujicalin® – the unique DCPA, 2015, 1–15. https://www.fujichemical.co.jp/english/medical/medicine/fujicalin/fujicalin_brochure.pdf.
   Google Scholar
• Product information brochure: SYLOID® 244 FP silica for food and pharmaceutical applications. Grace Davison Materials and Packaging Technologies. 2009, 1–2.
   Google Scholar
• Goncalves, I. L.; Gaelzer, M. M.; de Azambuja, G. O.; Salbego, C. G.; Eifler-Lima, V. L. A Complete Study of Doxazosin Characterization. Drug Anal. Res. 2017, 1, 56–60. DOI: 10.22456/2527-2616.73960.
   Google Scholar
• Patil, K. S.; Hajare, A. A.; Manjappa, A. S.; More, H. N.; Disouza, J. I. Design Development, in Silico and in Vitro Characterization of Docetaxel-Loaded TPGS/Pluronic F 108 Mixed Micelles for Improved Cancer Treatment. J. Drug Deliv. Sci. Technol. 2021, 65, 102685. DOI: 10.1016/j.jddst.2021.102685.
   Web of Science ®Google Scholar
• Hajare, A.; Dol, H.; Patil, K. Design and Development of Terbinafine Hydrochloride Ethosomal Gel for Enhancement of Transdermal Delivery: In Vitro, in Vivo, Molecular Docking, and Stability Study. J. Drug Deliv. Sci. Technol. 2021, 61, 102280. DOI: 10.1016/j.jddst.2020.102280.
   Web of Science ®Google Scholar
• Patil, S. S.; Chougale, R. D.; Manjappa, A. S.; Disouza, J. I.; Hajare, A. A.; Patil, K. S. Statistically Developed Docetaxel-Laden Mixed Micelles for Improved Therapy of Breast Cancer. OpenNano 2022, 8, 100079. DOI: 10.1016/j.onano.2022.100079.
   Google Scholar